Search for: "SHIRE US INC."
Results 41 - 60
of 101
Sorted by Relevance
|
Sort by Date
29 Mar 2010, 5:00 am
Shire, Inc., 2010 WL 937279 (Pa. [read post]
31 Dec 2008, 9:00 am
In re Transkaryotic Therapies, Inc., 954 A.2d 346 (Del. [read post]
22 Jul 2008, 12:15 pm
That Yetter would choose to use Emmens as a reference at the very time Emmens was seeking information on behalf of Shire creates at least the appearance of a conflict of interest. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
27 May 2010, 3:20 am
Nycomed US Inc. et al. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
14 Jul 2010, 6:47 pm
(Patent Docs) Lialda (Mesalazine /Mesalamine) – US: Patent infringement complaint following Paragraph IV certification: Shire Development Inc. et al. v. [read post]
23 Sep 2007, 2:28 pm
Shire US, Inc., 415 F. [read post]
4 Aug 2010, 12:21 am
Roxane Laboratories Inc. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals,… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’… [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint… [read post]
25 Jan 2023, 6:13 am
As for Ryne Miller, he said Miller is employed by Debtor West Realm Shires, Inc., “but has no day-to-day responsibilities. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix… [read post]
17 Jul 2017, 4:20 pm
Watson Pharmaceuticals, Inc. [read post]
11 Jun 2018, 8:38 am
,Inc. v. [read post]
7 Nov 2014, 5:52 am
Most warnings concern a product’s use – that if you use (or don’t use) the product in a certain way, you are likely to get hurt; and if you follow the warning, you won’t. [read post]
31 Oct 2008, 12:15 pm
See In re Netsmart Techs., Inc. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
